[Press release] Bioplus KOSDAQ listing request for preliminary examination

By 2021년 April 28일July 23rd, 2021No Comments

Published date: April 26, 2021

The Korea Exchange announced on the 26th that Refine, YM Tech, Bioplus, Mro, and Silicon2 have requested a preliminary examination for listing on the KOSDAQ.


Bioplus is a company specializing in biomaterials such as anti-adhesion agents.Last year, sales were 24.4 billion won and operating profit was 12.3 billion won. The main organizer is Kiwoom Securities


Author bioplubiz

More posts by bioplubiz

Leave a Reply